⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SGMT News
Sagimet Biosciences Inc. Series A Common Stock
Form 8-K
sec.gov
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH
globenewswire.com
SGMT
Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
SGMT
Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
globenewswire.com
SGMT